Insiders / Cabell Christopher / Activity

Activity — Cabell Christopher

2 moves.

BiggestBiggest buysBiggest sellsHighest impact
InsidersInstitutions
DateActionCompanyValueShares ΔPosition afterImpact
Feb 21, 2026OtherIKT
Inhibikase Therapeutics, Inc.
Common Stock
$0-338K
-33.33%
676,564
0.48% of shares
low
Jan 5, 2026GrantIKT
Inhibikase Therapeutics, Inc.
Stock Option (Right to Buy)
—+900K
900,117
0.65% of shares
low
← PrevPage 1 of 1Next →